ROCHESTER, N.Y., May 23, 2011 (GLOBE NEWSWIRE) -- NaturalNano, Inc. (OTCBB:NNAN) () announced today financial results for the first Quarter of 2011, highlighted by increases in orders for NNAN's Halloysite Nanotubes (HNT) for the launch of nail polish products for the European market. This anticipates the introduction of cosmetic products containing HNT in markets outside the USA. The European launch of a range of nail polish products that incorporate NaturalNano's HNT in Fiabila's nail polish accounted for initial orders that doubled the quantity of HNT required by Fiabila for their range of USA nail polish products with HNT. Fiabila is a global leader in the manufacturing of private label nail polish products in the USA and Europe.
Acting CEO and President James Wemett said, "We continue to be pleased with the progress being made at NaturalNano in the first quarter. We have lowered operating costs and see growth in revenues from NaturalNano's HNT and from Combotexs businesses." Wemett also noted, "There remains a steady demand for a range of our products and our R&D facility continues to stay busy working with a number of companies ranging from Fortune 100 to small businesses on many projects."
NNAN owns a majority interest in Combotexs which markets high quality Patient Safety Checklists Boards for Hospitals and Healthcare facilities. ( http://checklistboards.com/ ) These Patient Safety Checklists Boards improve team dynamics and help in error prevention for patients.
About NaturalNano, Inc.
NaturalNano, Inc. (OTCBB:NNAN) is a materials science company focused on developing and commercializing advanced nanocomposites. The Company is focused on additive technologies and processes, including its proprietary Pleximer that adds value to industrial polymers, plastics and composites. NaturalNano holds and/or licenses 20 patents and applications relating to Halloysite, as well as proprietary know-how for its extraction and separation processes, compositions, and derivatives. www.naturalnano.com
Cautionary Statement Regarding Forward-Looking Statements: Contains forward-looking statements regarding future events and future performance that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-K and quarterly reports on Form 10-Q filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.
CONTACT: Jim Wemett email@example.com NaturalNano, Inc. 585-267-4848 Gabriel Rodriguez E Relations Group, Inc. 623-255-5750